Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
From Critical Care Explorations. In this study, the authors report the prevalence of, and evaluate risk factors for, the development of hypertriglyceridemia (defined as a serum triglyceride level of > 400 mg/dL) in patients with coronavirus disease 2019 who received propofol.
Kovacevic MP, Dube KM, Lupi KE, et al.
Estimated Time: 23:27